Severity
Moderate
FDA Drug recall · Reported June 23, 2021
Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine
Dash Xclusive recalled Imperia Elita Vitaccino Coffee, 10 g sachets, 15 sachets per box, Global Beauty Technolog… - a moderate-severity action.
Imperia Elita Vitaccino Coffee, 10 g sachets, 15 sachets per box, Global Beauty Technolog… was recalled by Dash Xclusive in June 23, 2021. Reason: Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sib…. Check the official notice for the remedy. Verify recall #D-0628-2021 with the FDA Drug before acting.
The recall
Dash Xclusive issued this moderate-severity FDA Drug recall-Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sib….
Sourced from official FDA Drug enforcement records. Verify recall #D-0628-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0628-2021) was formally reported on June 23, 2021, with the manufacturer initiating the action on May 11, 2021. It is classified under Moderate severity (Class II), with a current status of Ongoing. Dash Xclusive is listed as the recalling firm, operating out of Glendale, CA. Federal records list the affected scope as 25 pieces (boxes containing 15 sachets).
The documented reason for this recall is: Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
25 pieces (boxes containing 15 sachets)
Related Recalls
6
5 from same agency
Imperia Elita Vitaccino Coffee, 10 g sachets, 15 sachets per box, Global Beauty Technologies, Manufactured for: Imperia-Elita Ltd. & Co, KG D- 35435 Wettenberg
Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0628-2021 |
| Date reported | June 23, 2021 |
| Date initiated | May 11, 2021 |
| Recalling firm | Dash Xclusive |
| Firm location | Glendale, CA |
| Affected scope | 25 pieces (boxes containing 15 sachets) |
| Distribution | Nationwide within the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 23, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.